Legend Biotech (LEGN) Asset Utilization Ratio (2020 - 2025)
Historic Asset Utilization Ratio for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to 110.05.
- Legend Biotech's Asset Utilization Ratio rose 14336.59% to 110.05 in Q3 2025 from the same period last year, while for Sep 2025 it was 110.05, marking a year-over-year increase of 14336.59%. This contributed to the annual value of 0.36 for FY2024, which is 9876.98% up from last year.
- Per Legend Biotech's latest filing, its Asset Utilization Ratio stood at 110.05 for Q3 2025, which was up 14336.59% from 113.22 recorded in Q2 2025.
- In the past 5 years, Legend Biotech's Asset Utilization Ratio registered a high of 113.86 during Q1 2025, and its lowest value of 0.0 during Q2 2021.
- Its 5-year average for Asset Utilization Ratio is 39.03, with a median of 21.66 in 2023.
- In the last 5 years, Legend Biotech's Asset Utilization Ratio plummeted by 3025.5% in 2023 and then soared by 5400499.14% in 2024.
- Quarter analysis of 5 years shows Legend Biotech's Asset Utilization Ratio stood at 0.09 in 2021, then increased by 25.53% to 0.12 in 2022, then surged by 36951.55% to 43.21 in 2023, then skyrocketed by 154.1% to 109.79 in 2024, then grew by 0.24% to 110.05 in 2025.
- Its last three reported values are 110.05 in Q3 2025, 113.22 for Q2 2025, and 113.86 during Q1 2025.